PSME3 and pancreatic adenocarcinoma: The combined analysis demonstrates a prominent elevation in PSME3 mRNA expression across several cancer types, including BLCA, BRCA, CESC, CHOL, COAD, Diffuse Large B-Cell Lymphoma (DLBC), ESCA, GBM, HNSC, KICH, Kidney Renal Papillary Cell Carcinoma (KIRP), Acute Myeloid Leukemia (LAML), Low-Grade Glioma (LGG), LIHC, LUAD, LUSC, Ovarian Cancer (OV), Pancreatic Ductal Adenocarcinoma (PAAD), PRAD, READ, Skin Cutaneous Melanoma (SKCM), STAD, Testicular Germ Cell Tumor (TGCT), Thymoma (THYM), and UCEC.